IGC Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGC Pharma and other ETFs, options, and stocks.About IGC
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development.
IGC Key Statistics
Stock Snapshot
As of today, IGC Pharma(IGC) shares are valued at $0.32. The company's market cap stands at 31.88M, with a P/E ratio of -5.46.
During the trading session on 2026-04-27, IGC Pharma(IGC) shares reached a daily high of $0.34 and a low of $0.32. At a current price of $0.32, the stock is +0.2% higher than the low and still -5.1% under the high.
Trading volume for IGC Pharma(IGC) stock has reached 218.38K, versus its average volume of 4.69M.
The stock's 52-week range extends from a low of $0.24 to a high of $0.50.
The stock's 52-week range extends from a low of $0.24 to a high of $0.50.
IGC News
IGC Pharma (IGC) announced the addition of Kerwin Medical Center in Dallas, Texas as a clinical site in the Company’s Phase 2 CALMA trial evaluating IGC-AD1 for...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.